NCT00385450View on ClinicalTrials.gov

Cardiopulmonary Bypass-Induced Lymphocytopenia and the Potential Effects of Protease Inhibitor

PHASE1TerminatedINTERVENTIONAL

Enrollment

41

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Cardiopulmonary Bypass

Interventions

DRUG

Nelfinavir/placebo

1250mg/twice each day/four days.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER